tiprankstipranks
NovaBridge Biosciences (NBP)
NASDAQ:NBP
US Market
NBP
NovaBridge Biosciences
RESEARCH TOOLSreports
Want to see NBP full AI Analyst Report?

NovaBridge Biosciences (NBP) Financial Statements

425 Followers

NovaBridge Biosciences Financial Overview

NovaBridge Biosciences's market cap is currently $271.15M. The company's EPS TTM is $-0.22; its P/E ratio is -57.60; NovaBridge Biosciences is scheduled to report earnings on April 7, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Dec 23Mar 23Dec 21
Income Statement
Total Revenue¥ 0.00¥ 0.00¥ 4.49M¥ -10.70M¥ 88.03M
Gross Profit¥ -6.00M¥ 0.00¥ 4.49M¥ -248.80M¥ 41.59M
Operating Income¥ -660.93M¥ -375.36M¥ -511.16M¥ -366.08M¥ -2.07B
EBITDA¥ -93.41M¥ -373.45M¥ -344.25M¥ -51.23M¥ -2.06B
Net Income¥ -46.27M¥ -162.26M¥ -1.47B¥ -2.51B¥ -2.33B
Balance Sheet
Cash & Short-Term Investments¥ 210.84M¥ 173.40M¥ 2.29B¥ 3.45B¥ 670.96M
Total Assets¥ 260.52M¥ 212.68M¥ 2.61B¥ 4.07B¥ 5.63B
Total Debt¥ 3.07M¥ 3.88M¥ 133.87M¥ 38.29M¥ 112.45M
Net Debt¥ -207.56M¥ -64.38M¥ -2.01B¥ -3.18B¥ -3.41B
Total Liabilities¥ 29.58M¥ 11.52M¥ 894.81M¥ 1.07B¥ 1.04B
Stockholders' Equity¥ 230.94M¥ 201.16M¥ 1.72B¥ 3.01B¥ 4.59B
Cash Flow
Free Cash Flow¥ -20.60M¥ -52.72M¥ -73.02M¥ -1.15B¥ -1.00B
Operating Cash Flow¥ -20.60M¥ -52.67M¥ -72.85M¥ -1.10B¥ -973.09M
Investing Cash Flow¥ 104.97M¥ -135.97M¥ -107.63M¥ 458.38M¥ -727.21M
Financing Cash Flow¥ 57.73M¥ -334.89K¥ -8.25M¥ 42.36M¥ 593.92M
Currency in CNY

NovaBridge Biosciences Earnings and Revenue History

Income Statement >

NovaBridge Biosciences Debt to Assets

Balance Sheet >

NovaBridge Biosciences Cash Flow

Cash Flow >

NovaBridge Biosciences Forecast EPS vs Actual EPS

Earnings >